Heart failure with reduced ejection fraction (HFrEF) is a common condition in the UK that is
increasingly managed with devices including cardiac resynchronisation therapy (CRT) …

Cardiac resynchronization therapy (CRT) is recommended in international guidelines for
patients with heart failure due to important left ventricular systolic dysfunction (or heart failure …

Cardiac resynchronization has emerged as a highly effective therapy for heart failure.
However, up to 40% of patients do not benefit from this treatment. In this Review, we discuss …

Abstract Funding Acknowledgements Type of funding sources: None. Background Cardiac
resynchronization therapy (CRT) has become a standard treatment for patients with heart …

Abstract Aims Up to 30–45% of implanted patients are non‐responders to CRT. We
evaluated the role of a 'CRT team'using cardiac magnetic resonance (CMR) and longitudinal …

With improved segmentation and image registration tools, data acquired using CMR can
help with planning and intraprocedural guidance as well as with defining etiology of heart …

Background Cardiac resynchronization therapy (CRT) is an established treatment in
advanced heart failure (HF). However, an important subset does not derive a significant …

Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart
failure with impaired left ventricular (LV) systolic function and a wide QRS complex. Early …

Methods and results We retrospectively enrolled 72 heart failure patients, 38 affected by
dilated cardiomyopathy (DCM) and 34 by ischemic dysfunction, with left bundle branch …

Cardiac resynchronisation therapy (CRT) is an effective treatment for patients with advanced
heart failure (HF), New York Heart Association class (NYHA) III or IV, a reduced left …